Neurol. praxi. 2013;14(2):105-108

Neuromyotonia

MUDr.Jana Junkerová1, MUDr.Vítězslav Novák2
1 Neurologická klinika FN Ostrava
2 Oddělení imunologie a alergologie, Zdravotní ústav se sídlem v Ostravě

We have described case of the young man with a rare diagnosis of acquired neuromyotonia with neuromuscular signs and symptoms of

autonomic dysfunction. Except specific electromyographic findings, the diagnosis is documented by positive antibodies against voltage-

-gated slow potassium channels. Due the assumption of paraneoplastic etiology the patient underwent comprehensive examination

with no evidence of malignancy. The patient was treated with immunosuppressive, immunomodulatory therapy and symptomatic medications.

Remission was achieved within several months and it is a question wether it was treatment effect or spontaneous remission.

Keywords: neuromyotonia, Isaacs syndrom, myokymia, anti VGKC

Published: April 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Junkerová J, Novák V. Neuromyotonia. Neurol. praxi. 2013;14(2):105-108.
Download citation

References

  1. Bednařík J, Ambler Z, Růžička E, a kol. Klinická neurologie: část speciální I. Praha: Triton, 2010: s 707.
  2. Bednařík J, Kadaňka Z. Volitional and stimulation induced neuromyotonic discharges: unusual electrophysiological pattern in acquired neuromyotonia. J Neurol Neurosurg Psychiatry. 2001; 70: 406-407. Go to original source... Go to PubMed...
  3. Gutmann L, Gutmann L. Myokymia and neuromyotonia 2004. J Neurol 2004; 251: 138-142. Go to original source... Go to PubMed...
  4. Han IK, Newsom-Davis J. Neuromyotonia (Isaacs Syndrome). In: Lane RJM. Handbook of muscle disease. New York: M. Dekker, 1996: 355-363.
  5. Kadaňka Z, Bednařík J. Neuromyotonie - nová kanalopatie. Čes Slov Neurol Neurochir 2000; 63/96: 128-133.
  6. Latta J, Ehler E, Zámečník J. Získaná neuromyotonie s nevelkými centrálními příznaky s průkazem protilátek proti napěťově řízeným kaliovým kanálům - kazuistika. Čes Slov Neurol Neurochir 2009; 72/105: 373-377.
  7. Maddison P. Neuromyotonia. Clin Neurophysiol 2006; 117: 2118-2127. Go to original source... Go to PubMed...
  8. Oh SJ. Principles of clinical electromyography: case studies. Baltimore: Williams & Wilkins 1998: 604.
  9. Trip J, Drost G, van Engelen BG, Faber CG. Drug treatment for myotonia. Cochrane Database Syst Rev 2006; CD004762. Go to original source...
  10. Valls-Solé J, Montero J. Role of EMG evaluation in muscle hyperactivity syndromes. J Neurol 2004; 25: 251-260. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.